Position in INCY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$442,663,677
-$50,496,117 QoQ
Shares Held
4,703,184
-5.8% QoQ
Ownership
2.35%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.93023874889862.ToString("F0")%
Shared 0.ToString("F0")%
None 0.06976125110138154.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,556,641,344 across 524 Biotechnology names. INCY ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
This page
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $442,663,677 | 4,703,184 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $493,159,794 | 4,993,012 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $380,472,077 | 4,486,170 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $296,080,480 | 4,347,731 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $254,793,854 | 4,207,991 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $279,048,739 | 4,040,086 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $260,181,233 | 3,936,176 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $245,307,194 | 4,046,638 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $252,940,875 | 4,439,896 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $268,329,799 | 4,273,448 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $240,756,128 | 4,167,494 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $253,823,752 | 4,077,490 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $286,315,094 | 3,961,742 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $310,710,932 | 3,868,413 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $251,223,537 | 3,769,861 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $283,540,248 | 3,732,266 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $291,398,730 | 3,669,085 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $283,187,622 | 3,858,142 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $263,132,952 | 3,825,719 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $305,060,175 | 3,626,057 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $274,954,777 | 3,383,226 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $283,074,148 | 3,254,474 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $288,385,322 | 3,213,565 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $324,686,145 | 3,122,883 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $220,202,536 | 3,006,999 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||